142 results on '"Khan, Husain Yar"'
Search Results
2. Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy
3. Connecting the Human Microbiome and Pancreatic Cancer
4. A New Anticancer Bisflavan-3-Ol from Boerhavia elegans
5. Targeting guanine nucleotide exchange factors for novel cancer drug discovery
6. Molecular analysis of XPO1 inhibitor and gemcitabine–nab‐paclitaxel combination in KPC pancreatic cancer mouse model
7. Anti-proliferative potential of cyclotetrapeptides from Bacillus velezensis RA5401 and their molecular docking on G-Protein-Coupled Receptors
8. Correction to: Connecting the human microbiome and pancreatic cancer
9. Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers
10. Pro-oxidant DNA Breakage Induced by the Interaction of L-DOPA with Cu(II): A Putative Mechanism of Neurotoxicity
11. Desmiflavanoside, a New Bioactive Flavonoid Glycoside Isolated from Desmidorchis flava
12. Editorial: Emerging talents in pharmacology of anti-cancer drugs 2022
13. Data from Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers
14. Supplementary Figures 1-4, Tables 1-2 from Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers
15. Anti-proliferative and computational studies of two new pregnane glycosides from Desmidorchis flava
16. Editorial: Novel immunological characteristics and immunotherapeutic targets in pancreatic cancer.
17. Supplementary Data from Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma
18. Supplementary Data from Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study
19. A phase I study of CPI-613 (devimistat) in combination with chemoradiation in patients with pancreatic adenocarcinoma.
20. Mobilization of copper ions in human peripheral lymphocytes by catechins leading to oxidative DNA breakage: A structure activity study
21. KRAS G12D targeted therapies for pancreatic cancer: Has the fortress been conquered?
22. Two pyrolysate products from Omani frankincense smoke: First evidence of thermal aromatization of boswellic acids
23. Nizwaside: a new anticancer pregnane glycoside from the sap of Desmidorchis flava
24. Abstract 5315: Anti-tumor activity of KRASG12C inhibitors is enhanced when combined with Cdc42 effector p21-activated kinase 4 targeting agents
25. Association of PAK4 expression with overall survival in patients with non-small cell lung cancer (NSCLC).
26. Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C–Mutant Cancers
27. Molecular profiling of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in cellular and LSL-Kras G12D/+; Trp53 fl/+; Pdx1-Cre (KPC) pancreatic cancer model
28. PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma
29. Pro-oxidant DNA Breakage Induced by the Interaction of L-DOPA with Cu(II): A Putative Mechanism of Neurotoxicity
30. Plant polyphenol induced cell death in human cancer cells involves mobilization of intracellular copper ions and reactive oxygen species generation: A mechanism for cancer chemopreventive action
31. Nuclear Export Inhibitor KPT-8602 Synergizes with PARP Inhibitors in Escalating Apoptosis in Castration Resistant Cancer Cells
32. Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study
33. Roles of CRAC channel in cancer: implications for therapeutic development
34. Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth
35. Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma
36. Synthesis of new boswellic acid derivatives as potential antiproliferative agents
37. Synthesis of new triterpenic monomers and dimers as potential antiproliferative agents and their molecular docking studies
38. Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance
39. Synthesis of new boswellic acid derivatives as potential antiproliferative agents
40. Synthesis of new boswellic acid derivatives as potential antiproliferative agents.
41. Desmiflavasides A and B: Two new bioactive pregnane glycosides from the sap of Desmidorchis flava
42. Bioactive chemical constituents from the resin of Aloe vera
43. ChemInform Abstract: Aloeverasides A and B: Two Bioactive C‐Glucosyl Chromones from Aloe vera Resin.
44. A norterpenoid and tripenoids from Commiphora mukul: isolation and biological activity
45. Aloeverasides A and B: Two Bioactive C‐Glucosyl Chromones from Aloe vera Resin
46. Synthesis of new triterpenic monomers and dimers as potential antiproliferative agents and their molecular docking studies.
47. A norterpenoid and tripenoids from Commiphora mukul: isolation and biological activity.
48. Plant polyphenol induced cell death in human cancer cells involves mobilization of intracellular copper ions and reactive oxygen species generation: A mechanism for cancer chemopreventive action
49. Mobilization of Intracellular Copper by Gossypol and Apogossypolone Leads to Reactive Oxygen Species-Mediated Cell Death: Putative Anticancer Mechanism.
50. Cancer Therapy by Catechins Involves Redox Cycling of Copper Ions and Generation of Reactive Oxygen Species.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.